? Eculizumab, complement inhibitor in severe COVID19 | Dr RR Baliga's 'Got Knowledge Doc?' Podkasts for Physicians |
Will Complement Inhibition be the New Target in Treating COVID-19 Related Systemic Thrombosis? | Circulation https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.120.047419#.XqjUc7YNhYU.twitter
Not Medical Advice or Opinion
